you are absolutely correct,and I appreciate your p
Post# of 9122
NNLX did give a potential pricing of 15M for Europe and ca 35 million for China.
But my point has been the general negativity/impatience since the July 12,2017 update whereby NNLX made some hard decisions to take this commercial by being willing to license/ sell geographic patents/ partner in Europe and China so they can fund expansion and the N-assay etc.
I reference the ZN board (on the basher site unusually) where many have made serious attempts to value huge oil fields,even claiming the largest oil field in the world for ZN, even though the company hasnt even proven or claimed commercial oil yet, as being more typical of longs attitudes.
Except for mits and maybe 1 or 2 others,plus machs posts (see the header) commenting on such potential pricing,there's been a lot of impatience, apparently partly or largely based on past initiatives which are deemed to have gone nowhere.
Each initiative has to be given a fair opportunity to play out in real world timing-not the unrealistic timing/expectations of some who dont understand how time consuming such negotiations etc are. Large company dd from beginning to final agreement can often take 3 years for a jv arrangement bc all kinds of considerations and contingencies etc have to be accounted for.
As I said, serious negotiations re Europe could not begin until Apr 11,2018 when the EU time frame for opposition ended and for China when somebody there is willing to take on the task of protecting their license in the old west style of Chinese 'steal anything you can" IP environment. Eastern philosophies dont have a historical reference for justice,property rights or righteousness,just tiannamin (sp?) squares.
I would suggest that in the next update and on a more regular basis (meaning when other updates are presented) NNLX comment on any initiatives which are still ongoing such as the Africa TB project so stockholders have a more comprehensive less in the dark view, bc people,especially in penny stocks,tend to think the worst.
biotechs and mining tend to be some of the toughest and longest playing games which test peoples mettle. I knew many pennies didnt even have a product but i just recently read ''most" pennies dont even have a product, which surprised even me.
NNLX has game changing products and revenue- hopefully inching ever closer to net revenue- but like many is having trouble fully commercializing due to financial limitations. Many pennies take the shortcuts of poisonous financing or bad jv etc arrangements, both of which end up destroying development stage companies. If NNLX had done that we wouldnt even be here.
You already know my wishlist- updating to otc current so the investor pool/pps can expand considerably and the ratio between longs and shorters improve etc,taking away several reasons why shorters target 'no info' co's. That is a tradeoff, like many, NNLX has apparently made to survive financially,though i think the benefits would outweigh the costs.